Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 11Tumor-Agnostic 3Head & Neck 3Gynecologic 3Gastrointestinal 3Genitourinary 2Sarcoma 1Other hematologic neoplasm 1Other 1Dermatologic 1

Conditions

Testicular Germ Cell Tumor 1Sarcoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypnosis × Genitourinary × Clear all
NCT07614620 2026-05-29

HYPNO-AJA2

Institut Bergonié

Phase NA Not yet recruiting
70 enrolled
BreastGenitourinaryGynecologicSarcoma

Testicular Germ Cell Tumor, Breast Neoplasms, Ovarian Neoplasms, Sarcoma

NCT03423927 2018-02-06

Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer Patients

University of Liege

Phase NA Completed
46 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡